The Alliance for Clinical Trials in Oncology has launched the ASPIRE trial-a large-scale, Phase III clinical study investigating whether adding chemotherapy to current standard treatments can extend ...

This large-scale, high-quality trial compares a promising alternative screening test to PSA. This may be the breakthrough for prostate cancer screening that we have all been waiting for,” said Kevin C ...

Australian men of all ages will soon be able to receive blood tests for prostate cancer as part of major changes to how the ...

His advocacy has since expanded beyond the clinic through speaking engagements, media appearances and partnerships with ...

A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL ...

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than current tests, according to a U.K.-wide study led by UCL researchers. The ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

A new drug combo is offering hope for men with advanced prostate cancer. Adding the targeted cancer drug niraparib to hormone therapy reduced the risk of prostate tumor growth and slowed symptom ...

In a population-based study, patients with lower urinary tract symptoms (LUTS) or urinary tract infections (UTIs) were more than fourfold more likely to undergo prostate biopsy but showed 44% lower ...

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a side effect so debilitating that patients often refuse the life-saving ...